ArticleReproductive medicine and biology
Epigenetic Changes in the Mature Uterus Following Neonatal Feeding of Tamoxifen in Female ICR Mice.
Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyperestrogenic imprinting and developmental origins of endometriosis and adenomyosis.Human reproduction open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate changes in immunoexpression of proteins involved in epigenetic regulation in the uterus in female ICR mice following neonatal exposure to tamoxifen. Methods: Thirty-two neonatal mice were randomly assigned to 2 groups: the control and the tamoxifen-treated group. At post-natal day 5 and 42, 8 mice each from the two groups were sacrificed and their uterine tissues were harvested and processed for histology and immunohistochemistry analyses. The immunostaining of Hdac1-3, Dnmt1, Dnmt3a, Kat2a, Ehmt2, Jmjd3, Setdb1, Ezh2, Suz12, Tet1-3, and Six1, an estrogen responsive protein known to regulate endometrial aberrations following developmental exposure to xenobiotic estrogens, was evaluated. Results: At adulthood, tamoxifen-exposed mice exhibited elevated endometrial staining of Hdac1, Setdb1, Suz12, Dnmt1, Dnmt3a, and Six1, but reduced staining of Hdac3, Kat2a, Ezh2, Jmjd3, and Tet1 in the endometrium. In the myometrium, Dnmt1, Dnmt3a, and Six1 staining was elevated, whereas Hdac3, Kat2a, and Jmjd3 staining was decreased. Conclusions: Neonatal tamoxifen exposure induces possibly lasting remodeling of uterine epigenetic regulators as well as Six1 overexpression in female ICR/CD-1 mice, especially in the endometrium. Collectively, these findings indicate that neonatal tamoxifen exposure in female ICR/CD-1 mice not only induces adenomyosis but also might sear a lasting exposure imprint on the reproductive tract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.